Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

Human Genomics(2021)10.1186/s40246-021-00326-3Source: DataRank Database

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy is a research paper published in Human Genomics (2021). On theSindex it has a DataRank of 0. It has been cited 56 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access56 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (26)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Michela Biancolella ORCID,Ruty Mehrian‐Shai ORCID,Vito Luigi Colona ORCID,Anderson F. Brito ORCID,Nathan D. Grubaugh ORCID

Live enrichment

PubMed:19022398

National Institutes of Health

Grant: AA028432

Fondazione Roma

Grant: Prot 317A/I

National Institutes of Health

Grant: 3R21AA028432-02S1

Identification of Biomarkers and Novel Pathways of Alcoholic Liver Disease by Leveraging Metabolomics, Tissue Imaging Mass Spectrometry, and Integrative Machine Learning

goldLicense: cc-by

publisherhttps://humgenomics.biomedcentral.com/counter/pdf/10.1186/s40246-021-00326-3

publisherhttps://link.springer.com/content/pdf/10.1186/s40246-021-00326-3.pdf

publisherhttps://link.springer.com/article/10.1186/s40246-021-00326-3/fulltext.html

repositoryhttps://art.torvergata.it/bitstream/2108/276244/2/s40246-021-00326-3.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8107019

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

COVID-19 Vaccines610ReviewQH426-470Settore MED/03 - GENETICA MEDICASettore MEDS-01/A - Genetica medicaGeneticsHumansGenetic Predisposition to DiseasePandemicsVaccinesVaccines, SyntheticPandemicPopulation HealthSARS-CoV-2Health PolicyVariantsRAntibodies, MonoclonalCOVID-19CoronavirusMedicinemRNA Vaccines

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 1 of Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking

10.6084/m9.figshare.20882185.v1figshare

Additional file 1 of Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking

10.6084/m9.figshare.20882185figshare

Additional file 2 of Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking

10.6084/m9.figshare.20882188.v1figshare

Additional file 2 of Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking

10.6084/m9.figshare.20882188figshare

COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy

10.6084/m9.figshare.c.5417730figshare